InvestorsHub Logo
Followers 43
Posts 17844
Boards Moderated 0
Alias Born 09/16/2012

Re: Extremist223 post# 99603

Saturday, 02/04/2017 6:18:41 AM

Saturday, February 04, 2017 6:18:41 AM

Post# of 725648
Of course it does. There's no excuse to exclude interim analysis. At the very least just for ongoing biomarker data.

Keep them in the dark while ever lower cash raises totals nice sums.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News